UW Spinout, Beat Bio, Gets $2.5M to Treat Heart Failure Xconomy Beat, at that time, was seeking to develop stem cells to treat congestive heart failure, although today's announcement of the financing makes no mention of stem cells. Today's statement doesn't say much about Beat's scientific strategy, but does say ... |
